Esperion Therapeutics | ESPR - Trade Debtors


Esperion Therapeutics reported $140.19M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Amarin USD 126.83M 477K Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Cipla INR 74.61B 19.39B Sep/2025
CSL USD 4.32B 1.35B Dec/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Geron USD 37.66M 1.71M Sep/2025
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sanofi EUR 397M 100M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024